Article
Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in Brazil.
JCO global oncology - 1 Nov 2024
Dienstmann Rodrigo, da Silva Leonard M, Orpinelli Ramos do Rego Fernanda, Muniz Rodrigues Amanda, Koyama Fernanda Christtanini, Galindo Layla Testa, de Bustamante Fernandes Carolina, de Souza Bruno Batista, Paes Rafael Duarte, Montella Tatiane, de Marchi Pedro, Jeha Araújo Breno, Ferrari Bruno Lemos, Mathias Clarissa, Pereira Emilio, Zalis Mariano Gustavo, Leslin Chesley, Ferreira Carlos Gil
Abstract excerpt
PURPOSE: Tissue inadequacy and operational challenges may limit lung cancer comprehensive biomarker testing. Here, we describe the initial implementation of a tailored tissue molecular journey at Oncoclínicas Precision Medicine Laboratory in Brazil, which includes fast-track (FT) non-next-generation sequencing (NGS) assays combined with a broad NGS panel. METHODS: From 2021 to 2023, all nonsquamous lung cancer...
Topics
Join the communities discussing this publication.
